title: Relation of pathologic Q waves at presentation and time to streptokinase therapy with early changes in infarct-related artery flow and ventricular wall motion.
authors.affiliation: Cardiovascular Research Unit, Green Lane Hospital, Auckland, New Zealand.
authors.forename: C
authors.initials: C
authors.lastname: Wong
authors.forename: J K
authors.initials: JK
authors.lastname: French
authors.forename: A
authors.initials: A
authors.lastname: Zambanini
authors.forename: J
authors.initials: J
authors.lastname: Andrews
authors.forename: P E
authors.initials: PE
authors.lastname: Aylward
authors.forename: A A
authors.initials: AA
authors.lastname: Adgey
authors.forename: M J
authors.initials: MJ
authors.lastname: Frey
authors.forename: H D
authors.initials: HD
authors.lastname: White
mesh_terms: D000368:Aged; D017023:Coronary Angiography / Q000379:methods; D003326:Coronary Circulation / Q000187:drug effects*; D004334:Drug Administration Schedule; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D011336:Probability; D012720:Severity of Illness Index; D013300:Streptokinase / Q000627:therapeutic use*; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome; D016277:Ventricular Function, Left / Q000187:drug effects*
chemical_list: D005343:Fibrinolytic Agents; D013300:Streptokinase